ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
12.40
+0.26 (2.14%)
At close: Sep 20, 2024, 4:00 PM
13.02
+0.62 (5.00%)
After-hours: Sep 20, 2024, 4:37 PM EDT
ClearPoint Neuro Revenue
ClearPoint Neuro had revenue of $7.86M in the quarter ending June 30, 2024, with 32.07% growth. This brings the company's revenue in the last twelve months to $28.07M, up 29.33% year-over-year. In the year 2023, ClearPoint Neuro had annual revenue of $23.96M with 16.56% growth.
Revenue (ttm)
$28.07M
Revenue Growth
+29.33%
P/S Ratio
11.05
Revenue / Employee
$262,327
Employees
107
Market Cap
342.19M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 23.96M | 3.40M | 16.56% |
Dec 31, 2022 | 20.55M | 4.25M | 26.09% |
Dec 31, 2021 | 16.30M | 3.47M | 27.05% |
Dec 31, 2020 | 12.83M | 1.61M | 14.37% |
Dec 31, 2019 | 11.22M | 3.86M | 52.54% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Accolade | 431.53M |
OraSure Technologies | 273.54M |
Personalis | 80.03M |
Pulmonx | 76.58M |
Editas Medicine | 67.03M |
MeiraGTx Holdings | 8.12M |
Ocugen | 7.26M |
Immutep | 2.56M |
CLPT News
- 25 days ago - ClearPoint Neuro Announces Early Repayment of $10 Million Note - GlobeNewsWire
- 5 weeks ago - ClearPoint: Growth Tailwinds Are Only Just Beginning To Emerge (Rating Downgrade) - Seeking Alpha
- 6 weeks ago - ClearPoint Neuro: My Favorite Growth Stock - Seeking Alpha
- 6 weeks ago - ClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024 - GlobeNewsWire
- 3 months ago - ClearPoint Neuro: Solid Progress Still Not Reflected In The Share Price - Seeking Alpha
- 3 months ago - ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial - GlobeNewsWire
- 3 months ago - Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons - PRNewsWire